• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症中的糖基化:一种可能的修饰因素及干预靶点

Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention.

作者信息

Brás Inês Caldeira, König Annekatrin, Outeiro Tiago Fleming

机构信息

Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center Göttingen, Göttingen, Germany.

Max Planck Institute for Experimental Medicine, Göttingen, Germany.

出版信息

J Huntingtons Dis. 2019;8(3):245-256. doi: 10.3233/JHD-190366.

DOI:10.3233/JHD-190366
PMID:31322580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6839463/
Abstract

Glycation is the non-enzymatic reaction between reactive dicarbonyls and amino groups, and gives rise to a variety of different reaction products known as advanced glycation end products (AGEs). Accumulation of AGEs on proteins is inevitable, and is associated with the aging process. Importantly, glycation is highly relevant in diabetic patients that experience periods of hyperglycemia. AGEs also play an important role in neurodegenerative diseases including Alzheimer's (AD) and Parkinson's disease (PD). Huntington's disease (HD) is a hereditary neurodegenerative disease caused by an expansion of a CAG repeat in the huntingtin gene. The resulting expanded polyglutamine stretch in the huntingtin (HTT) protein induces its misfolding and aggregation, leading to neuronal dysfunction and death. HD patients exhibit chorea and psychiatric disturbances, along with abnormalities in glucose and energy homeostasis. Interestingly, an increased prevalence of diabetes mellitus has been reported in HD and in other CAG triplet repeat disorders. However, the mechanisms underlying the connection between glycation and HD progression remain unclear. In this review, we explore the possible connection between glycation and proteostasis imbalances in HD, and posit that it may contribute to disease progression, possibly by accelerating protein aggregation and deposition. Finally, we review therapeutic interventions that might be able to alleviate the negative impact of glycation in HD.

摘要

糖基化是活性二羰基化合物与氨基之间的非酶促反应,会产生多种不同的反应产物,即所谓的晚期糖基化终末产物(AGEs)。AGEs在蛋白质上的积累不可避免,且与衰老过程相关。重要的是,糖基化在经历高血糖期的糖尿病患者中高度相关。AGEs在包括阿尔茨海默病(AD)和帕金森病(PD)在内的神经退行性疾病中也起重要作用。亨廷顿舞蹈病(HD)是一种遗传性神经退行性疾病,由亨廷顿基因中CAG重复序列的扩增引起。由此产生的亨廷顿蛋白(HTT)中扩展的聚谷氨酰胺片段会导致其错误折叠和聚集,进而导致神经元功能障碍和死亡。HD患者表现出舞蹈症和精神障碍,以及葡萄糖和能量稳态异常。有趣 的是,据报道HD和其他CAG三联体重复序列疾病中糖尿病的患病率增加。然而,糖基化与HD进展之间联系的潜在机制仍不清楚。在本综述中,我们探讨了糖基化与HD中蛋白质稳态失衡之间的可能联系,并假定它可能通过加速蛋白质聚集和沉积而导致疾病进展。最后,我们综述了可能能够减轻糖基化对HD负面影响的治疗干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca00/6839463/4dc3663dcf01/jhd-8-jhd190366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca00/6839463/4dc3663dcf01/jhd-8-jhd190366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca00/6839463/4dc3663dcf01/jhd-8-jhd190366-g001.jpg

相似文献

1
Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention.亨廷顿舞蹈症中的糖基化:一种可能的修饰因素及干预靶点
J Huntingtons Dis. 2019;8(3):245-256. doi: 10.3233/JHD-190366.
2
Nucleic Acid Therapeutics in Huntington's Disease.亨廷顿舞蹈病中的核酸疗法
Recent Pat Biotechnol. 2019;13(3):187-206. doi: 10.2174/1872208313666190208163714.
3
Glycation potentiates neurodegeneration in models of Huntington's disease.糖基化增强亨廷顿病模型中的神经退行性变。
Sci Rep. 2016 Nov 18;6:36798. doi: 10.1038/srep36798.
4
Protective Effects of Antioxidants in Huntington's Disease: an Extensive Review.抗氧化剂在亨廷顿病中的保护作用:一篇综述。
Neurotox Res. 2019 Apr;35(3):739-774. doi: 10.1007/s12640-018-9989-9. Epub 2019 Jan 11.
5
The RAGE receptor and its ligands are highly expressed in astrocytes in a grade-dependant manner in the striatum and subependymal layer in Huntington's disease.在亨廷顿舞蹈症患者的纹状体和室管膜下层中,RAGE受体及其配体在星形胶质细胞中以分级依赖的方式高表达。
J Neurochem. 2015 Sep;134(5):927-42. doi: 10.1111/jnc.13178. Epub 2015 Jul 1.
6
Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.亨廷顿病猴诱导多能干细胞源性神经祖细胞衍生的星形胶质细胞改善亨廷顿病表型。
PLoS One. 2019 Mar 21;14(3):e0214156. doi: 10.1371/journal.pone.0214156. eCollection 2019.
7
Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.表达突变全长亨廷顿舞蹈病(HD)互补DNA的转基因小鼠:亨廷顿舞蹈病运动变化和选择性神经元丢失的范例
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45. doi: 10.1098/rstb.1999.0456.
8
Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington's disease.探讨高迁移率族蛋白 B1(HMGB1)在亨廷顿病发病机制中的作用。
J Mol Med (Berl). 2020 Mar;98(3):325-334. doi: 10.1007/s00109-020-01885-z. Epub 2020 Feb 8.
9
Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington's disease.旨在全面理解线粒体功能障碍和氧化应激在亨廷顿病发病机制和病理生理学中的作用。
J Neurosci Res. 2019 Nov;97(11):1455-1468. doi: 10.1002/jnr.24492. Epub 2019 Jul 15.
10
Bioenergetics in Huntington's disease.亨廷顿舞蹈病中的生物能量学
Ann N Y Acad Sci. 1999;893:203-13. doi: 10.1111/j.1749-6632.1999.tb07827.x.

引用本文的文献

1
Concomitant pathologies and their impact on Huntington's disease. A brief review of current evidence.伴随病变及其对亨廷顿舞蹈症的影响。当前证据简述。
J Neural Transm (Vienna). 2025 Jun 21. doi: 10.1007/s00702-025-02957-5.
2
An exploratory metabolomic comparison of participants with fast or absent functional progression from 2CARE, a randomized, double-blind clinical trial in Huntington's disease.对 2CARE 中功能快速或无进展的参与者进行探索性代谢组学比较,2CARE 是一项针对亨廷顿病的随机、双盲临床试验。
Sci Rep. 2024 Jan 11;14(1):1101. doi: 10.1038/s41598-023-50553-y.
3
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes.

本文引用的文献

1
Acceleration of protein glycation by oxidative stress and comparative role of antioxidant and protein glycation inhibitor.氧化应激加速蛋白质糖化作用及抗氧化剂和蛋白质糖化抑制剂的比较作用。
Mol Cell Biochem. 2019 Sep;459(1-2):61-71. doi: 10.1007/s11010-019-03550-7. Epub 2019 May 17.
2
Beneficial Role of Phytochemicals on Oxidative Stress and Age-Related Diseases.植物化学物质对氧化应激和与年龄相关疾病的有益作用。
Biomed Res Int. 2019 Apr 7;2019:8748253. doi: 10.1155/2019/8748253. eCollection 2019.
3
Pinocembrin Protects from AGE-Induced Cytotoxicity and Inhibits Non-Enzymatic Glycation in Human Insulin.
多巴胺在葡萄糖稳态调节、2型糖尿病发病机制及多巴胺活性/代谢受损的慢性病症中的作用:对病理生理及治疗目的的意义
Biomedicines. 2023 Nov 7;11(11):2993. doi: 10.3390/biomedicines11112993.
4
Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective review.胰岛素信号通路 PI3K/Akt/mTOR 损伤及 AGEs 诱导的胰岛素抵抗与糖尿病和神经退行性疾病:综述展望。
Mol Cell Biochem. 2023 Jun;478(6):1307-1324. doi: 10.1007/s11010-022-04587-x. Epub 2022 Oct 29.
5
Role of RAGE in the Pathogenesis of Neurological Disorders.晚期糖基化终产物受体(RAGE)在神经退行性疾病发病机制中的作用。
Neurosci Bull. 2022 Oct;38(10):1248-1262. doi: 10.1007/s12264-022-00878-x. Epub 2022 Jun 21.
6
Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers.神经退行性疾病和神经创伤中的糖组学和糖蛋白质组学技术:迈向个体化标志物。
Cells. 2022 Feb 8;11(3):581. doi: 10.3390/cells11030581.
7
Autophagy and Glycative Stress: A Bittersweet Relationship in Neurodegeneration.自噬与糖基化应激:神经退行性变中的复杂关系
Front Cell Dev Biol. 2021 Dec 23;9:790479. doi: 10.3389/fcell.2021.790479. eCollection 2021.
8
Effect of Advanced Glycation End-Products and Excessive Calorie Intake on Diet-Induced Chronic Low-Grade Inflammation Biomarkers in Murine Models.晚期糖基化终产物和过量热量摄入对小鼠模型饮食诱导的慢性低度炎症生物标志物的影响。
Nutrients. 2021 Sep 2;13(9):3091. doi: 10.3390/nu13093091.
9
Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease.免疫性疾病相关额颞叶痴呆中糖蛋白通路的改变。
Front Immunol. 2021 Sep 1;12:736260. doi: 10.3389/fimmu.2021.736260. eCollection 2021.
10
Editorial: Brain Insulin Resistance in Neurodevelopmental and Neurodegenerative Disorders: Mind the Gap!社论:神经发育和神经退行性疾病中的脑胰岛素抵抗:注意差距!
Front Neurosci. 2021 Aug 10;15:730378. doi: 10.3389/fnins.2021.730378. eCollection 2021.
白杨素可防止 AGE 诱导的细胞毒性并抑制人胰岛素的非酶糖基化。
Cells. 2019 Apr 26;8(5):385. doi: 10.3390/cells8050385.
4
New directions in therapeutics for Huntington disease.亨廷顿舞蹈症治疗的新方向
Future Neurol. 2018 May;13(2):101-121. doi: 10.2217/fnl-2017-0035. Epub 2018 May 29.
5
An active cognitive lifestyle as a potential neuroprotective factor in Huntington's disease.积极的认知生活方式是亨廷顿病的潜在神经保护因素。
Neuropsychologia. 2019 Jan;122:116-124. doi: 10.1016/j.neuropsychologia.2018.10.017. Epub 2018 Oct 26.
6
Therapeutic approaches to Huntington disease: from the bench to the clinic.亨廷顿病的治疗方法:从实验室到临床。
Nat Rev Drug Discov. 2018 Oct;17(10):729-750. doi: 10.1038/nrd.2018.133. Epub 2018 Sep 21.
7
The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality.晚期糖基化终产物在衰老和代谢性疾病中的作用:关联与因果关系的桥梁。
Cell Metab. 2018 Sep 4;28(3):337-352. doi: 10.1016/j.cmet.2018.08.014.
8
Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease.二甲双胍逆转亨廷顿病的早期皮质网络功能障碍和行为改变。
Elife. 2018 Sep 4;7:e38744. doi: 10.7554/eLife.38744.
9
Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson's Disease.帕金森病中糖基化和糖基化修饰与炎症及线粒体功能障碍的关联
Front Neurosci. 2018 Jun 7;12:381. doi: 10.3389/fnins.2018.00381. eCollection 2018.
10
Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.α-突触核蛋白糖基化与抗糖尿病药物在帕金森病中的作用。
J Parkinsons Dis. 2018;8(1):33-43. doi: 10.3233/JPD-171285.